Invivo Molecular Imaging LLC., announces that it has become the first commercial provider of mobile PET/CT imaging services to purchase the Siemens Biograph 16 TruePoint PET/CT scanner in a mobile configuration.  According to Blaine Beining CNMT, Director of Operations for Invivo Molecular Imaging LLC, “The addition of this technology is consistent with the philosophy of Invivo Molecular Imaging LLC. to bring the best technology possible to the mobile marketplace.  We understand the role cutting edge technology will play in improving the exams we perform today and tomorrow as new biomarkers become available,”

The Biograph TruePoint is a flexible, high-powered medical imaging platform from Siemens and offers a wide range of performance options to enhance image resolution and quality.  It provides physicians with the most functional information possible for earlier and more accu­rate diagnoses, allowing for more effective treatment planning and monitoring, avoiding unnecessary invasive surgery, and improving the overall care for patients. The system completely integrates the functional sensitivity of PET with the rich anatomical detail of diagnostic multislice CT, enabling physicians to more accurately detect tumors and to pinpoint their precise location in the body. Biograph TruePoint is designed specifically for hybrid modality integration, providing the clinical accuracy and speed physicians and their patients need.

 

“This is an important step in the process of making cutting edge healthcare more accessible”; said Doug Darrow, Vice President of Molecular Imaging, Siemens Healthcare.  “Being able to offer some of the latest innovations in PET/CT imaging today in a mobile coach environment, offers a new paradigm to the high-end mobile coach imaging market.” 

The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 51,000 employees worldwide and operates around the world. In fiscal year 2011 (to September 30), the Sector posted revenue of 12.5 billion euros and profit of around 1.3 billion euros. For further information please visit: www.siemens.com/healthcare.

About Invivo Molecular Imaging LLC:  Invivo Molecular Imaging LLC. is a privately owned subsidiary of Diagnostic Laboratories LLC. that provides cutting edge mobile and fixed PET/CT imaging services.  Invivo Molecular Imaging LLC. specializes in implementing new technology and biomarkers in the clinical and research setting.  For further information please visit:  www.invivomi.com